Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 2,821	$ 3,701
Accounts receivable – net of related allowances for credit loss of $619 and $588	10,214	11,466
Inventories	2,791	3,123
Prepaid and other current assets	14,077	14,818
Total current assets	29,903	33,108
Property, plant and equipment	330,486	329,630
Less: accumulated depreciation and amortization	(202,028)	(202,185)
Property, Plant and Equipment – Net	128,458	127,445
Goodwill – Net	67,895	67,895
Licenses – Net	124,502	124,092
Other Intangible Assets – Net	5,346	5,354
Investments in and Advances to Equity Affiliates	2,810	3,533
Operating Lease Right-Of-Use Assets	21,619	21,814
Other Assets	20,340	19,612
Total Assets	400,873	402,853
Current Liabilities
Debt maturing within one year	13,757	7,467
Note payable to DIRECTV	0	130
Accounts payable and accrued liabilities	38,389	42,644
Advanced billings and customer deposits	3,922	3,918
Dividends payable	2,082	2,014
Total current liabilities	58,150	56,173
Long-Term Debt	123,727	128,423
Deferred Credits and Other Noncurrent Liabilities
Deferred income taxes	57,294	57,032
Postemployment benefit obligation	7,060	7,260
Operating lease liabilities	18,413	18,659
Other noncurrent liabilities	27,883	28,849
Total deferred credits and other noncurrent liabilities	110,650	111,800
Stockholders’ Equity
Common stock ($1 par value, 14,000,000,000 authorized at March 31, 2023 and December 31, 2022: issued 7,620,748,598 at March 31, 2023 and December 31, 2022)	7,621	7,621
Additional paid-in capital	120,774	123,610
Retained (deficit) earnings	(15,187)	(19,415)
Treasury stock (471,514,050 at March 31, 2023 and 493,156,816 at December 31, 2022, at cost)	(16,166)	(17,082)
Accumulated other comprehensive income	2,354	2,766
Noncontrolling interest	8,950	8,957
Total stockholders’ equity	108,346	106,457
Total Liabilities and Stockholders’ Equity	400,873	402,853
Series A (48,000 issued and outstanding at March 31, 2023 and December 31, 2022)
Stockholders’ Equity
Preferred stock ($1 par value, 10,000,000 authorized at March 31, 2023 and December 31, 2022):	0	0
Series B (20,000 issued and outstanding at March 31, 2023 and December 31, 2022)
Stockholders’ Equity
Preferred stock ($1 par value, 10,000,000 authorized at March 31, 2023 and December 31, 2022):	0	0
Series C (70,000 issued and outstanding at March 31, 2023 and December 31, 2022)
Stockholders’ Equity
Preferred stock ($1 par value, 10,000,000 authorized at March 31, 2023 and December 31, 2022):	$ 0	$ 0